Generated by DeepSeek V3.2| Annual Meeting of the Society for Neuroscience | |
|---|---|
| Name | Annual Meeting of the Society for Neuroscience |
| Abbreviation | SfN |
| Discipline | Neuroscience |
| Publisher | Society for Neuroscience |
| History | 1971–present |
| Frequency | Annual |
| Venue | Various convention centers across the United States |
| Attendance | ~30,000 |
| Website | https://www.sfn.org/ |
Annual Meeting of the Society for Neuroscience. It is the largest annual global conference dedicated to the scientific study of the brain and nervous system, organized by the Society for Neuroscience. The event serves as a central hub for presenting cutting-edge research, fostering collaboration among scientists from diverse disciplines, and shaping the future direction of the field. Attendees include researchers, clinicians, students, and professionals from institutions worldwide, such as the National Institutes of Health, Max Planck Society, and Harvard University.
The first meeting was held in 1971 in Washington, D.C., following the founding of the Society for Neuroscience in 1969 by a group of scientists including Ralph W. Gerard. Its primary purpose was to create a dedicated forum for the rapidly expanding, interdisciplinary field of neuroscience, distinct from existing societies focused on physiology or psychology. Early meetings were significantly smaller, but growth accelerated with advances in areas like molecular biology and neuroimaging. The conference's mission has consistently been to disseminate research, promote education, and advocate for public policies supporting brain science, influencing organizations like the National Institute of Neurological Disorders and Stroke and the Brain Initiative.
The meeting typically spans five days in the autumn, rotating among major United States cities like San Diego, Chicago, and New Orleans. The scientific program is organized by a committee of elected members from the Society for Neuroscience council. Core events include thousands of brief oral presentations in parallel sessions and expansive poster halls where researchers present data. Major scheduled events are the opening lecture, often delivered by a notable figure like Eric Kandel or Carla Shatz, and the Presidential Special Lecture. The large exhibition hall features booths from hundreds of entities, including Thermo Fisher Scientific, Elsevier, and Janelia Research Campus.
The program encompasses the entire breadth of neuroscience, organized into thematic tracks such as cellular and molecular neuroscience, systems neuroscience, cognitive neuroscience, and diseases of the nervous system. Recent themes have prominently featured neurotechnology, computational neuroscience, and translational research for conditions like Alzheimer's disease and autism spectrum disorder. Symposia and mini-symposia are curated to highlight convergent research, such as the neural basis of consciousness or optogenetics applications. "Hot Topics" sessions address rapidly evolving areas, including the role of glia in neurodegeneration or advances in connectomics.
Annual attendance regularly exceeds 30,000 delegates from over 80 countries, making it one of the world's largest scientific gatherings. Its impact is profound, serving as the premier venue for launching new concepts, publishing influential studies in journals like *Nature* and *Neuron*, and forging international collaborations. The meeting significantly influences career trajectories through networking, the Job Center, and awards like the Peter and Patricia Gruber International Research Award. It also plays a critical role in science policy, with events connecting researchers with policymakers from the United States Congress and agencies like the Food and Drug Administration.
The meeting has hosted landmark presentations, such as early reports on the discovery of mirror neurons and the development of CLARITY tissue imaging. The introduction of optogenetics by Karl Deisseroth and Ed Boyden was prominently featured, revolutionizing systems neuroscience. Controversies have also arisen within the scientific discourse presented, including debates on the amyloid hypothesis for Alzheimer's disease and the reproducibility of social neuroscience findings. Ethical and policy debates, such as those concerning chimpanzee research or the use of CRISPR in neural systems, have been vigorously discussed in dedicated sessions and panels.
Category:Neuroscience Category:Academic conferences Category:Science and technology in the United States